超声对早期乳腺癌患者腋窝分期的诊断准确性
该回顾性单中心研究纳入611例早期乳腺癌患者的622个腋窝,评估腋窝超声(联合或不联合空芯针活检)诊断腋窝淋巴结转移的准确性。基于日常解读,腋窝超声敏感度为53.3%(95%CI 46.4-60.1),特异度为93.6%(95%CI 90.8-95.8),准确度为79.7%(95%CI 76.4-82.8)。系统应用既往推荐的诊断标准并未提高常规解读腋窝超声的诊断准确性,作者结论认为单凭腋窝超声不足以准确识别或排除早期乳腺癌患者的腋窝转移。
要点
- 日常解读腋窝超声诊断腋窝淋巴结转移的敏感度仅53.3%,特异度93.6%。
- 系统应用既往推荐的诊断标准并未提高常规解读腋窝超声的诊断准确性。
- 单凭腋窝超声不足以准确识别或排除早期乳腺癌的腋窝转移。
核心结论
- 单凭腋窝超声的表现不足以准确识别或排除未经选择的早期乳腺癌患者的腋窝转移性疾病。
- 系统应用既往推荐的诊断标准并未提高常规解读腋窝超声的诊断准确性。
研究设计与样本
- 回顾性单中心研究,纳入611例连续早期乳腺癌患者的622个腋窝。
- 所有患者均接受腋窝超声联合或不联合空芯针活检,并以腋窝手术(前哨淋巴结活检和/或腋窝淋巴结清扫)为参考标准。
- 诊断结局指标包括敏感度、特异度、准确度、Youden指数和诊断比值比,分别基于日常常规解读和由两名盲法检查者基于既往推荐的诊断标准进行评估。
诊断标准与关键数值
- 基于日常常规解读,腋窝超声诊断腋窝淋巴结转移的敏感度为53.3%(95%CI 46.4-60.1)。
- 基于日常常规解读,腋窝超声诊断腋窝淋巴结转移的特异度为93.6%(95%CI 90.8-95.8)。
- 基于日常常规解读,腋窝超声诊断腋窝淋巴结转移的准确度为79.7%(95%CI 76.4-82.8)。
- 基于日常常规解读,腋窝超声诊断腋窝淋巴结转移的Youden指数为0.47(95%CI 0.40-0.54)。
- 基于日常常规解读,腋窝超声诊断腋窝淋巴结转移的诊断比值比为16.75(95%CI 10.37-27.05)。
临床应用与阅片要点
- 作者结论认为,单凭腋窝超声的表现不足以准确识别或排除未经选择的早期乳腺癌患者的腋窝转移性疾病。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Axillary ultrasound (AUS) is a standard procedure in the preoperative clinical identification of axillary metastatic lymph node (LN) involvement. It guides decisions about local and systemic therapy for patients with early breast cancer (EBC). But there is only weak evidence on the diagnostic criteria and standard interpretation. The aim of this study was to assess the performance of AUS in the detection and exclusion of LN metastases.
METHODS: In a retrospective single-center study, 611 consecutive EBC patients with 622 axillae underwent AUS +/- core needle biopsy (CNB) plus axillary surgery, i.e. sentinel lymph node biopsy and/or axillary lymph node dissection. For all patients, AUS image documentation of at least the most suspicious LN was saved during the initial diagnostic work-up. The diagnostic outcome measures were sensitivity, specificity, accuracy, Youden-index (YI), and diagnostic odds ratio (DOR) on the basis of the daily routine interpretation and on the basis of previously recommended diagnostic criteria by two blinded examiners.
RESULTS: On the basis of the daily routine interpretation, AUS had a sensitivity (95 % CI) of 53.3 % (46.4-60.1), a specificity (95 % CI) of 93.6 % (90.8-95.8), an accuracy (95 % CI) of 79.7 % (76.4-82.8), a YI (95 % CI) of 0.47 (0.40 - 0.54), and a DOR (95 % CI) of 16.75 (10.37-27.05). Systematic application of previously recommended diagnostic criteria did not improve the diagnostic accuracy of routinely interpreted AUS.
CONCLUSION: AUS performance alone is not sufficient to accurately identify or exclude axillary metastatic disease in unselected patients with EBC.
引用
- Riedel F, Schaefgen B, Sinn HP, et al. Diagnostic accuracy of axillary staging by ultrasound in early breast cancer patients. Eur J Radiol. 2020. PMID: 33338758. doi:10.1016/j.ejrad.2020.109468
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。